Isolation of plasmid pKM101 in the Stocker laboratory

Kristien Mortelmans1

  • 1SRI International, Biosciences Division, Microbiology Program, 333 Ravenswood Avenue, Menlo Park, CA 94025-3493, United States.

Mutation Research
|May 24, 2006
PubMed

Insights

The pKM101 plasmid significantly enhances the Salmonella/microsome mutation assay (Ames test), improving the detection of mutagens. This research explores its role in bacterial mutagenesis and its contribution to genetic toxicity testing.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • The Salmonella/microsome mutation assay (Ames test) is a crucial tool for detecting mutagens and assessing genetic toxicity.
  • Plasmid pKM101, a derivative of R46, has been instrumental in improving the sensitivity and effectiveness of the Ames test since its introduction.
  • The Ames test is widely required by regulatory agencies for the approval of new drugs and chemical agents.

Discussion:

  • This paper details the isolation and characterization of pKM101, highlighting its role as a mutagenesis-enhancing R plasmid.
  • It explores the molecular mechanisms underlying pKM101-mediated bacterial mutagenesis.
  • The research also pays tribute to Professor Bruce A.D. Stocker for his contributions to Salmonella genetics and plasmid research.

Key Insights:

  • Plasmid pKM101 has substantially improved the Ames test's ability to detect mutagens.
  • pKM101 aids in elucidating the molecular mechanisms of mutagenesis.
  • The plasmid is a valuable tool in predicting carcinogenicity and assessing genetic toxicity.

Outlook:

  • Continued research into pKM101 will further refine our understanding of bacterial mutagenesis.
  • The plasmid's application in genetic toxicity testing is expected to remain significant.
  • Further studies may uncover new applications for pKM101 in drug and chemical safety assessments.

Related Concept Videos